<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200302046662N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-03-07</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Investigation of the effect of cardiac rehabilitation on  patients with different types of heart rhythm management devices and their spouses</public_title>
      <acronym></acronym>
      <scientific_title>Investigation of the effect of cardiac rehabilitation via telenursing on sexual satisfaction and fatigue of patients with different types of heart rhythm management devices and their spouses at arrhythmias clinics affiliated to Shiraz University of Medical Sciences</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-05-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>68</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/46285</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Other design features: The present study will be conducted on couples and patients' spouses will be included.Therefore, the intervention group (34 patients plus 34 spouses) and the control group (34 patients plus 34 spouses) will total 68 couples (136 persons), Randomization description: Using the stratified random sampling method, here are the classes of Cardiac resynchronization therapy, implantable cardiac defibrillator  and pacemaker to fit each class, 14 patients with Cardiac resynchronization therapy, 22 patients with implantable cardiac defibrillator and 32 patients with Pacemakers will first be selected as available sampling in the aforementioned classes, and then random allocation using Random allocation Software to generate block randomization lists of each block size 2 or 4 2 blocks of 7, floor implantable cardioverter defibrillator The size of 2 blocks of 11 blocks and the pacemaker class 4 blocks of 8 blocks will be divided into control and patient groups, Blinding description: In order to single blind , questionnaires will be collected by the first researcher and assigned to intervention and control groups by the second researcher, so the outcome assessor will be kept blind. Also, the person analyzing the data will not be aware of the intervention and control groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Patients with different types of heart rhythm management devices. Condition 2: Spouses of patients with different types of heart rhythm management devices.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention group (patient plus his / her spouse) during an 8-week period including 8 sessions of cardiac rehabilitation: 2 in-person sessions including training and counseling on fatigue and sexual satisfaction for two weeks (one session per week) and after in-person sessions starting with the third week of the intervention, 6 non-face-to-face sessions will be followed by 6-week telephone follow_ups (one call per week by the nurse). Also, educational-motivational text messages will be sent three times a week from the beginning of the rehabilitation period. Patients will perform exercise sessions at home according to the cardiac electrophysiology practitioner and based on the instruction booklet we will provide. Intervention 2: Control group: There is no intervention, and patients will receive only routine training and routine care.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is "No more information"</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahnaz Rakhshan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Fatemeh (P.B.U.H) School of Nursing and Midwifery, Namazi Hospital, Namazi Square</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۳۱۱۹ - ۷۱۹۳۶</zip>
        <telephone>0098 7136474254-8</telephone>
        <email>rakhshanm@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahnaz Rakhshan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Fatemeh (P.B.U.H) School of Nursing and Midwifery, Namazi Hospital, Namazi Square</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۳۱۱۹ - ۷۱۹۳۶</zip>
        <telephone>0098 7136474254-8</telephone>
        <email>rakhshanm@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Has one of a different types of heart rhythm management devices and has been implanted for at least three months
Be married
Only have one spouse
18 to 70 years old
Not diagnosed mental illness and acute cognitive disorders
Not having severe orthopedic, neurological, visual and hearing problems
Ability to understand and speak and read and write Persian language
Phone access (fixed and mobile) after discharge
Have sexual activity</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Incidence of unstable angina
Uncontrolled blood pressure, resting systole greater than 180 mmHg or diastolic resting time greater than 110 mmHg
Severe neurological, orthopedic and musculoskeletal problems that occur during the study and prevent them from being active
The patient's unwillingness to continue attending the study
Not attending one of the pre- or post-test sessions
Not attending one of the in person sessions</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention group (patient plus his / her spouse) during an 8-week period including 8 sessions of cardiac rehabilitation: 2 in-person sessions including training and counseling on fatigue and sexual satisfaction for two weeks (one session per week) and after in-person sessions starting with the third week of the intervention, 6 non-face-to-face sessions will be followed by 6-week telephone follow_ups (one call per week by the nurse). Also, educational-motivational text messages will be sent three times a week from the beginning of the rehabilitation period. Patients will perform exercise sessions at home according to the cardiac electrophysiology practitioner and based on the instruction booklet we will provide.</i_keyword>
      <i_keyword>Control group: There is no intervention, and patients will receive only routine training and routine care.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Level of sexual satisfaction in Hudson Index of Sexual Satisfaction questionnaire. Timepoint: At baseline (before intervention) and 2 months after intervention. Method of measurement: Hudson Index of Sexual Satisfaction.</prim_outcome>
      <prim_outcome>Fatigue score on the Fatigue Severity Scale Questionnaire. Timepoint: At baseline (before intervention) and 2 months after intervention. Method of measurement: Fatigue Severity Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-01-15</approval_date>
        <contact_name>Ethics committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Fatemeh(P.B.U.H)School of Nursing and Midwifery, Namazi Hospital, Namazi Square Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
